Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering…
ICMIs Contact Center Expo 2025 Unveils Keynote Speakers
Event Takes Place October 27-30 in Orlando, FloridaSAN FRANCISCO--(BUSINESS WIRE)--ICMI’s Contact Center…
Red Bali Kratom Launch by Happy Go Leafy Sold Out Within Hours
Glendale, CA, Sept. 15, 2025 (GLOBE NEWSWIRE) -- In an exciting turn…
Nacuity Pharmaceuticals Announces Positive Data from Clinical Trial Evaluating NPI-001 to Treat Retinitis Pigmentosa Associated with Usher Syndrome
September 11, 2025 09:00 ET Â | Source: Nacuity Pharmaceuticals, Inc. NPI-001 shows…
The National Geographic Society and PepsiCo Launch New Food for Tomorrow Program Focused on Regenerative Agriculture
WASHINGTON, Sept. 4, 2025 /PRNewswire/ -- Today, the National Geographic Society and…
Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint…
Water Crisis to Water Security: The Art of Living’s Scalable Model for a Water Positive India
BENGALURU, India, Aug. 26, 2025 /PRNewswire/ -- Water is India's lifeline -…
KuCoin Launches “Anti-Phishing Month” Campaign, Empowering Users Through Education, Incentives, and Defense
PROVIDENCIALES, Turks and Caicos Islands, Aug. 25, 2025 /PRNewswire/ -- KuCoin, a…
Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients
August 21, 2025 01:30 ET Â | Source: NICOX SA Press Release Nicox…
Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results
Posts Positive Organic Growth and Adjusted EBITDA‎1 of 23.5% of Revenue CINCINNATI,…